Corporate
News
LR Health & Beauty SE: Written Procedure under the 2024/2028 Bonds has been successfully concluded
LR Health & Beauty SE: Written Procedure under the 2024/2028 Bonds has been successfully concluded
Ahlen, 28 November 2025 – On 14 November 2025, LR Health & Beauty SE (the “Company”) initiated a written procedure under the terms and conditions for the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”) to request certain temporary waivers relating to postponement of interest payments and non-compliance with the maintenance test (including the leverage covenant) for a period up to and including 28 February 2026 (the “Written Procedure”).
Deadline for voting in the Written Procedure was 15:00 hrs CET today. Votes representing a sufficient part of the adjusted nominal amount of the Bonds were obtained in order to form a quorum and a requisite majority of the adjusted nominal amount voted in favour of the temporary waivers in the Written Procedure.
The agent under the Bonds has further confirmed that the conditions set out in section 4 (Effectiveness) in the notice of the Written Procedure have been fulfilled. Consequently, the temporary waivers are effective immediately.
For further information regarding the Written Procedure, please refer to the notice of the Written Procedure which is accessible on the Company’s website at https://ir.lrworld.com/en/bond/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
Notice of results of Written Procedure under the Terms and Conditions
Denna kallelse till obligationsinnehavarna är endast utformad på engelska.
Stockholm, 28 November 2025
To the Bondholders in:
ISIN: NO0013149658 – LR Health & Beauty SE EUR 130,000,000 Senior Secured Callable Floating Rate Bonds 2024/2028
NOTICE OF RESULTS OF WRITTEN PROCEDURE UNDER THE TERMS AND CONDITIONS
Nordic Trustee & Agency AB (publ) acts as agent (the “Agent”) for the holders of the bonds (the “Bondholders”) in the above mentioned bond issue NO0013149658 with an aggregated amount outstanding of EUR 130,000,000 (the “Bonds”) issued by LR Health & Beauty SE (the “Issuer”).
All capitalised terms used herein and not otherwise defined in this notice shall have the meanings assigned to them in the terms and conditions of the Bonds as amended and/or restated from time to time (the “Terms and Conditions”).
Reference is made to the notice of written procedure dated 14 November 2025 (the “Written Procedure” and the “Notice of Written Procedure”) and the request for certain temporary waivers set out therein (the “Temporary Waivers”).
Votes representing a sufficient part of the Adjusted Nominal Amount of the Bonds have been obtained in order to form a quorum and a requisite majority of the Adjusted Nominal Amount voted in favour of the Temporary Waivers in the Written Procedure.
The conditions set out in section 4 (Effectiveness) in the Notice of the Written Procedure have been fulfilled.
In its capacity as Agent, the Agent hereby gives notice to the Bondholders that the Written Procedure has been concluded and that the Temporary Waivers have become effective.
______________________________________________
Stockholm, 28 November 2025
NORDIC TRUSTEE & AGENCY AB (PUBL)
as Agent
LR Health & Beauty SE publishes final results for the third quarter of 2025
LR Health & Beauty SE publishes final results for the third quarter of 2025
- Preliminary figures for Q3/9M 2025 confirmed: sales for 9M 2025 at EUR 208.8 million, EBITDA reported at EUR 16.3 million
- Focus on initiatives to optimise business processes and sustainably improve the capital and financing structure
- Forecast for the 2025 financial year confirmed
Ahlen, 28 November 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final results for the third quarter of 2025 and the first nine months of 2025, thereby confirming the preliminary figures announced on 24 October 2025.
In the third quarter of the 2025 financial year, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 66.0 million (previous year: EUR 69.4 million), bringing sales for the first nine months of 2025 to EUR 208.8 million (previous year: EUR 212.7 million). While market conditions in many regions remained characterized by weak consumer sentiment, two newly launched fragrance collections provided positive momentum in September.
EBITDA reported for the third quarter of 2025 amounted to EUR 2.9 million (Q3 2024: EUR 7.3 million), primarily impacted by lower sales and higher marketing and sales expenses. Consequently, EBITDA reported for the first nine months of 2025 came in at EUR 16.3 million (9M 2024: EUR 19.0 million). The normalized EBITDA reached EUR 3.8 million in the third quarter of 2025 (Q3 2024: EUR 8.7 million) and EUR 19.1 million for the nine-month period (9M 2024: EUR 23.1 million).
Outlook
Jörg Körfer, Chief Executive Officer (CEO) of LR Health & Beauty SE, commented:
“Our priority is to position the LR Group on a robust operational and financial footing for the future. In this context, we will develop a clear action plan to establish a solid financial base and strengthen the competitiveness of the LR Group through targeted strategic initiatives. Despite the current challenging market environment, we continue to see attractive potential in our product segments, which we intend to address even more effectively going forward.”
Based on the final results for the third quarter of 2025, LR confirms the sales and earnings guidance for the full year 2025 that was adjusted in October 2025. Accordingly, sales (revenue from goods sold) for the 2025 financial year are still expected to be in the range of EUR 276 million to EUR 281 million, and EBITDA reported is expected to remain between EUR 17.0 million and EUR 20.0 million.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds
LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds
Ahlen, 14 November 2025 – LR Health & Beauty SE (the “Company”) announced on 20 October 2025 that the board of the Company identified an expected breach of the leverage covenant requiring the Company to maintain a ratio of net debt to EBITDA of 4.50:1 as at 30 September 2025 (the “Leverage Covenant”) under the terms and conditions (the “Terms and Conditions”) of the 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”).
Today, the board of the Company decided to initiate a written procedure (the “Written Procedure”) among the holders of the Bonds (the “Bondholders”) in accordance with the Terms and Conditions.
For the period up to and including 28 February 2026, the Bondholders shall consent to temporarily waive any breach and/or event of default resulting from any (i) non-compliance with the maintenance test (including any potential breach of the Leverage Covenant), and (ii) postponement of interest payments under the Bonds due in November 2025 and February 2026 until such later date as will be set out in a restructuring proposal, provided that such date is approved by the Bondholders. A notice of the Written Procedure, including voting instructions, has today been sent by the agent under the Terms and Conditions to the direct registered owners and registered authorised nominees of the Bonds.
The last day for voting in the Written Procedure is 28 November 2025 and the voting record date is 17 November 2025. The Written Procedure may however be terminated before the expiry of the time period for replies if a requisite majority has been obtained.
The notice of the Written Procedure and further details are accessible on the Company’s website at https://ir.lrworld.com/en/bond/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE reports on business development in the third quarter of 2025
LR Health & Beauty SE reports on business development in the third quarter of 2025
- Sales of EUR 66.0 million in the third quarter of 2025; EUR 208.8 million in the first nine months of 2025
- EBITDA reported of EUR 2.9 million in the third quarter of 2025; EUR 16.3 million in the first nine months of 2025
- Successful relaunch of the fragrance segment and a well-stocked product pipeline create additional business opportunities for LR distributors
- Focus on developing an action plan with suitable measures to sustainably improve the capital and financing structure
- Sales and earnings guidance for fiscal year 2025 revised again
Ahlen, October 24, 2025 – LR Health & Beauty SE, Europe's leading digital social commerce company for high-quality nutritional supplements and beauty products, provides preliminary information on its business development in the third quarter of 2025 and in the first nine months of 2025. In the third quarter of the 2025 financial year, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 66.0 million according to preliminary figures, which corresponds to a decline of 5.0% compared to the corresponding quarter of the previous year (previous year: EUR 69.4 million). In the first nine months of 2025, sales amounted to EUR 208.8 million representing a decrease of 1.8% compared with the prior-year figure of EUR 212.7 million. The generally subdued consumer sentiment in the Western European markets also had a noticeable impact on the LR Group's business in the third quarter. By contrast, positive momentum has already come from the two new collections in the fragrance portfolio, which were successfully launched onto the market in September.
On the earnings side, based on preliminary figures, the company generated EBITDA reported of EUR 2.9 million in the third quarter of 2025. The significant decline of 59.9% compared to the previous year (Q3 2024: EUR 7.3 million) is mainly due to the lower sales and increased costs in the areas of marketing and sales. As a result, for the first nine months of 2025, EBITDA reported amounts to EUR 16.3 million (9M 2024: EUR 19.0 million). In addition, normalized EBITDA reached EUR 3.8 million in the third quarter of 2025 (Q3 2024: EUR 8.7 million) and EUR 19.1 million on a nine-month basis (9M 2024: EUR 23.1 million).
Jörg Körfer, CEO of LR Health & Beauty SE, explains: "In a market environment still characterized by high uncertainty and restrained consumer spending, we focus on deliberately strengthening the operating performance of the LR Group. The continuous optimisation and expansion of our product portfolio – most recently through the successful market launch of innovative fragrance lines – is an important strategic pillar. In addition, we want to align our processes even more closely with the needs of our distributors. The successfully conducted Business Days in September once again made it clear that together with our strong partner community, we can accomplish a great deal and make even better use of the potential in our business areas."
Expansion of the product portfolio
To mark its 40th anniversary, LR has realigned its fragrance portfolio and responds to consumer demand for particularly high-quality fragrance experiences with two new collections. The LR MOOD INFUSION line comprises 18 fragrances based on a patented mood technology and incorporates the latest scientific findings on the intensification of emotions. The second collection, LR ICONIC ELIXIRS, consists of four luxury perfumes that use rare essences such as Egyptian jasmine to create exceptional intensity and character. Both product lines feature improved formulas, high-quality packaging and the highest "Made in Germany" quality standards. In addition, LR has a well-stocked product pipeline to further complement the portfolio with suitable products and open up additional business opportunities for LR distribution partners.
Forecast 2025
In view of the challenging business development in the third quarter of 2025 and initiatives to secure sustainable financing for the LR Group, the Management Board has once again reassessed sales and earnings expectations. The Management Board now expects sales (revenue from goods sold) to be in the range of EUR 276 million to EUR 281 million for the full year 2025. Previously, sales were forecast to remain stable compared with the previous year (2024: EUR 289.2 million). EBITDA reported for the 2025 financial year is now expected to be between EUR 17.0 million and EUR 20.0 million, whereas the previous forecast was for EBITDA reported between EUR 24.0 million and EUR 27.0 million. In the fourth quarter of 2025, one-time effects in the low single-digit million euro range are expected to weigh on earnings in connection with initiatives to sustainably improve the financing situation.
"Our mission is clear: We want to make the LR Group operationally and financially sustainable for the future. From a financial point of view, we are in talks with the bond creditors of the 2024/2028 bond and have commissioned a restructuring report for support. This is intended to assist to develop an appropriate action plan for the company and to improve the capital and financing structure of the LR Group sustainably with appropriate measures," says Jörg Körfer, CEO of LR Health & Beauty SE.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE publishes figures for the first half of 2025 and adjusts its forecast for 2025
LR Health & Beauty SE publishes figures for the first half of 2025 and adjusts its forecast for 2025
- EUR 142.9 million in sales achieved in the first half of 2025
- EBITDA reported improved by 13.6% to EUR 13.3 million
- Newly appointed management team with CEO Jörg Körfer and Interim CFO Ante Franicevic drives further development of corporate strategy
- Planned discussions with bondholders of the 2024/2028 bond regarding a precautionary resolution on a waiver of compliance with the Leverage Covenant as at 30 September 2025 and an amendment to the bond terms
- Sales and earnings guidance for financial year 2025 adjusted
Ahlen, 28 August 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its results for the second quarter and the first half of 2025. In the second quarter of the financial year 2025, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 68.9 million (Q2 2024: EUR 70.7 million) – a decline of 2.6%. In the first half of the year, sales amounted to EUR 142.9 million, representing a slight decrease of 0.3% compared with the prior-year figure of EUR 143.3 million. This development reflects the generally subdued consumer sentiment, particularly noticeable in Western European markets.
In addition, LR Health & Beauty SE achieved EBITDA reported of EUR 13.3 million in the first six months of 2025, representing a significant increase of 13.6% compared with the prior-year period (H1 2024: EUR 11.7 million). In the prior-year period, refinancing costs incurred in connection with the redemption of the previous bond had weighed on earnings. Normalized EBITDA increased by 6.3% to EUR 15.3 million in the first half of 2025 (H1 2024: EUR 14.4 million).
Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations LR Health & Beauty SE, comments: “In the first half of 2025, we focused on further enhancing the foundations for the business success of our distributors. Our product innovations play an important role in this. Through regular product launches and the targeted expansion of our portfolio, we are opening up attractive business opportunities for our distributors in a generally challenging market environment.”
New leadership team with proven expertise
With a newly formed leadership team, LR is consistently driving the further development of its corporate strategy. As of 1 August 2025, Mr Jörg Körfer was appointed Chief Executive Officer (CEO). He brings extensive expertise in global direct sales from his many years of senior management positions at internationally operating companies, including Bofrost and Vorwerk. In addition, LR has strengthened its management team with the appointment of Mr Ante Franicevic, who serves as Interim Chief Financial Officer (CFO). Mr Franicevic contributes more than 20 years of senior management experience in finance at well-known retail and consumer brands such as Douglas, Jack Wolfskin and Metro.
Jörg Körfer, CEO of LR Health & Beauty SE, states: “As a newly formed leadership team, our clear goal is to continue LR’s success story as Europe’s leading social commerce company. Our Global Leader Convention in Berlin, marking the company’s 40th anniversary, and the Business Days in September provide an ideal opportunity to strengthen our engagement with our community members and to launch new business initiatives. Together with our distributors, we aim to make the company even stronger and more innovative, thereby ensuring sustainable success for LR in a challenging market environment.”
2024/2028 bond
Today, the Management Board of LR Health & Beauty SE resolved to initiate precautionary negotiations with the holders of the 2024/2028 bond (ISIN: NO0013149658) regarding a proposal to amend the bond terms and, if necessary, to request their consent to a waiver of the Leverage Covenant as at 30 September 2025. The background is a potential breach of the company’s obligation under Clause 13.2 of the bond terms, which requires the company to ensure that net debt in relation to EBITDA (the “Leverage Covenant”) does not exceed the threshold of 4.50:1 as at 30 September 2025. The Leverage Covenant was reduced from 4.75:1 to 4.50:1 as of 1 July 2025. Based on preliminary calculations, the Management Board currently assumes that the Leverage Covenant is unlikely to be met on the review date of 30 September 2025. This is due to EBITDA developing less favourably than expected, primarily due to increased or increasing costs in the areas of marketing and sales.
Outlook 2025
Furthermore, LR’s Management Board is adjusting the guidance for the 2025 financial year published on 25 April 2025. With regard to sales (revenue from goods sold), the Management Board now expects a stable development compared with the previous year. Previously, stable to moderately increasing sales had been forecast. EBITDA for the 2025 financial year is now expected to range between EUR 24.0 million and EUR 27.0 million – whereas the previous guidance anticipated significant EBITDA growth compared to the previous year’s figure of EUR 27.3 million. The revision of the EBITDA guidance is essentially due to increased or increasing costs in the areas of marketing and sales. This trend also continued in July, leading the Management Board to conclude that the previous guidance is unlikely to be achieved through catch-up effects or cost-saving measures.
The full report for the second quarter and the first half of 2025 will be available from 29 August 2025 on the corporate website: https://ir.lrworld.com/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Contact:
PR contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty welcomes Jörg Körfer as new CEO – focus remains on growth and operational excellence
LR Health & Beauty welcomes Jörg Körfer as new CEO – focus remains on growth and operational excellence
Ahlen, 21 July 2025 – LR Health & Beauty SE announces that Mr Jörg Körfer has been appointed Chief Executive Officer (CEO). He will take over the responsibilities of the previous members of the Management Board, Dr Andreas Laabs and Andreas Grootz, with effect from 1 August 2025. Both gentlemen will leave the company by mutual agreement on 31 July 2025. In order to further strengthen the management team in the future, the Supervisory Board is exploring options for another complementary member of the Management Board.
Jörg Körfer has extensive expertise in global direct sales from his many years of management experience with international companies. Among other things, he spent 14 years at Vorwerk (CEO Kobold and CEO Thermomix) and served as Chairman of the Advisory Board at Bofrost for six years, as well as acting as CEO in an advisory capacity. He will now bring this experience to LR and continue to exploit the full potential of Europe’s leading social commerce platform in line with the strategy that has been pursued.
The Supervisory Board would like to express its sincere thanks to the two departing members of the Management Board for their trust and dedication. Under Dr Laabs’ leadership in particular, LR has developed excellently over the past eleven years and is ideally positioned to enter its next phase of growth. Since joining LR in 2014, Dr Laabs has played a key role in shaping the company and successfully transformed LR from a traditional direct sales model into a globally active social commerce company. The key milestones of his tenure include the digitalisation of the business model, several of LR’s most successful product launches, and infrastructure projects such as the insourcing of Aloe Vera Drinking Gels in 2018 and the opening of the IT hub in Athens, all of which have contributed significantly to LR’s current position.
Andreas Grootz is leaving the company after fourteen years. He established capital market-compatible governance structures at LR and drove forward the opening of new markets.
The Supervisory Board is confident that Mr Körfer is the right successor to LR to continue the success story started by Dr Laabs and his team.
Contact:
Public Relations:
LR Global Holding
Almut Kellermeyer
Head of PR / Public Affairs
Kruppstraße 55
59227 Ahlen
Tel.: +49(0)2382 7813-106
Email: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
Investor Relations:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Tel.: +49(0)611 – 205855-23
Fax: +49(0)611 – 205855-66
Email: burbach@cometis.de
LR Health & Beauty SE grows profitably in the first quarter 2025
LR Health & Beauty SE grows profitably in the first quarter 2025
- Sales increased by 2.0% to EUR 74.0 million in the first quarter
- EBITDA reported significantly improved by 20.5% to EUR 7.4 million
- Digitalisation and process optimisation in logistics & IT increase efficiency
- Forecast for the financial year 2025 confirmed
Ahlen, 26 May 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its figures for the first quarter of 2025. In the first three months of the financial year 2025, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 74.0 million (Q1 2024: EUR 72.6 million). Despite the generally subdued consumer sentiment in Europe, the company was able to increase sales by 2.0% compared to the first quarter of the previous year.
Furthermore, EBITDA reported amounted to EUR 7.4 million (Q1 2024: EUR 6.1 million) in the first quarter of 2025, which corresponds to a significant increase of 20.5% compared to the same period of the previous year. On the one hand, both the sales growth achieved, and overall stable cost structures had a positive effect. On the other hand, one-off extraordinary effects due to the premature refinancing of the old bond burdened the EBITDA reported in the previous year’s quarter. In the first quarter of 2025, normalized EBITDA rose by 4.9% to EUR 8.2 million compared to the corresponding value of the previous year of EUR 7.8 million.
Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of LR Health & Beauty SE, comments: “The good start to the 2025 financial year has confirmed that we have set the course for profitable growth with our strategic growth initiatives such as the realignment of the career plan and the continuous expansion of our product range.
With the ongoing digitalisation of our business processes and the launch of our new logistics centre, we are also successfully working towards making our business even more efficient and profitable.”
Successful digitalisation of business processes
The logistics centre at the Ahlen site has been fully commissioned and now also enables direct deliveries to LR sales partners and customers in various markets. At the heart of the logistics centre is a state-of-the-art storage system that increases efficiency and improves scaling possibilities. The further digitalisation of business processes is reflected not only in the optimised logistics, but also in the expansion of the company's own IT infrastructure. The opening of the IT hub in Athens is helping to ensure that business applications can increasingly be developed and operated internally.
Dr. Andreas Laabs, CEO of LR Health & Beauty SE summarises: “Our partner community has started the new year with a lot of energy, and we have seen a great response to our Business Days. With the launch of the new LR Aloe Via Magic Power Duo skincare range, we have furthermore underpinned our high quality standards in the field of skincare. We aim to utilise the tailwind from the first quarter to continue our growth trajectory. On top of seasonal sales initiatives such as ‘Crazy Summer’, we are also planning a major new product launch for the second half of the year, which will give our partner community further impetus for sales."
Outlook 2025
LR Health & Beauty still expects to be able to consistently utilize the growth opportunities in the Health & Beauty segments despite the tense market situation in large parts of Europe. Based on conservative assumptions, the company continues to expect stable to moderately rising sales (revenue from goods sold) and significantly higher EBITDA for the 2025 financial year compared to the previous year.
The full report for the first quarter is available from today on the company website at https://ir.lrworld.com/.
In addition, the Sustainability Report 2024 is now available for download at https://ir.lrworld.com/en/sustainability/.
LR Group
Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Your Contacts:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de
LR Health & Beauty SE continues growth trajectory in the 2024 financial year
LR Health & Beauty SE continues growth trajectory in the 2024 financial year
- Sales increased to EUR 289.2 million
- EBITDA reported at EUR 27.3 million, burdened by one-off extraordinary effects
- Career plan realignment leads to significant boost in new sales careers
- Successful launch of new LR Aloe Via Magic Power Duo skincare range contributes to positive business outlook in 2025
- 2025 forecast: significant increase in EBITDA with stable to moderate sales growth
Ahlen, 25 April 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final audited financial results for 2024. With this, the Group confirms the preliminary figures for the 2024 financial year announced on 28 February 2025, according to which LR Health & Beauty SE achieved sales (revenue from goods sold) of EUR 289.2 million (2023: EUR 276.5 million), representing a year-on-year increase in sales of 4.6%. This increase was significantly driven by the realignment of the career plan, on the one hand, and the successful launches of the colour cosmetics line LR ZEITGARD Signature, and the intestinal metabolism treatment LR HEALTH MISSION, on the other. The LR Group therefore achieved its sales forecast for 2024, which it had raised in November to a range of EUR 288 to 292 million.
Furthermore, LR Health & Beauty SE achieved an EBITDA reported of EUR 27.3 million in the 2024 financial year, compared to EUR 31.4 million in the previous year. This was in line with the forecast for EBITDA reported, which had been adjusted in November to a range of EUR 26 to 29 million. In the reporting period, earnings development was particularly impacted by one-off, extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024. Normalized EBITDA amounted to EUR 32.6 million in 2024 (2023: EUR 35.4 million).
Dr Andreas Laabs, Chief Executive Officer (CEO) of LR Health & Beauty SE, elaborates on the Group’s strategic initiatives: “In 2024, we consistently executed our strategy and took a major step toward long-term corporate success with the realignment of our career plan. This year, we are again seeing a strong increase in the number of new distributors who are using our onboarding programmes to launch their careers. By continuing to digitalise our business processes, we are empowering our partner community to grow their careers successfully. At the same time, we are expanding our digital offering – whether through training, information, or sales initiatives.”
Innovative product launches drive new growth opportunities
In 2025, the LR Group will continue to focus on expanding and optimising its product portfolio. The new LR Aloe Via Magic Power Duo skincare range was successfully launched in April. This innovative skincare range features an even more powerful fermented aloe vera extract.
Valdemaras Gordinskis, the LR Group’s Vice President Global Controlling and Investor Relations, comments: “Processing aloe vera has always been one of LR’s core competencies. Now, with the unique combination of pure aloe vera leaf gel and fermented aloe vera, we have taken skincare a step further. With the patented Aloe Via Magic Power Duo product solution, we are setting new standards in skincare and expanding our range of health and beauty products. For LR, product innovation is an important pillar on the path to sustained profitable growth.”
Positive outlook for 2025
LR Health & Beauty SE is well positioned to take advantage of the attractive growth opportunities in the health & beauty sectors. Against a backdrop of high uncertainty in the market environment and continued consumer reticence, LR expects stable to moderately rising sales (revenue from goods sold) in the 2025 financial year, based on conservative assumptions. Furthermore, given the expected sales development, operational improvements and the absence of extraordinary effects compared to the previous year, the Group is expected to achieve a significant year-on-year increase in EBITDA.
The full 2024 Annual Report is available from today on the company website at https://ir.lrworld.com/. At the end of May 2025, LR will also publish the 2024 Sustainability Report and make it available for download here.
LR Group
Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Your Contacts:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de
LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024
LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024
8.0% increase in sales in Q4 2024 to EUR 76.5 million, confirming growth trend
Full-year sales at EUR 289.2 million, up 4.6% y-o-y
EBITDA reported of EUR 8.3 million in Q4 2024 and EUR 27.3 million in FY 2024 due to one-off charges
Realignment of career plan and successful product launches such as LR ZEITGARD Signature provide positive momentum in 2024 and beyond
Ahlen, 28 February 2025 - LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality nutritional supplements and cosmetic products, today publishes its figures for the fourth quarter of 2024 as well as preliminary sales and earnings figures for the full year 2024.
LR Health & Beauty SE closed the 2024 financial year with significant sales growth in the fourth quarter, confirming the growth trend of the third quarter. In the fourth quarter of 2024, LR achieved sales (revenue from goods sold) of EUR 76.5 million (Q4 2023: EUR 70.9 million), representing growth of 8.0%. For the full year 2024, LR Health & Beauty SE reports sales of EUR 289.2 million, compared to EUR 276.5 million in the previous year. This corresponds to an increase of 4.6% and is in line with the LR Group’s 2024 sales forecast of EUR 288 to 292 million, which had been raised in November.
“LR Group’s strong growth is confirmation that we are on the right track with our strategy. The positive performance in the final quarter of 2024 is primarily the result of the realignment of the career plan and the successful market launch of further product innovations. We’re constantly working to create the best possible conditions for the business success of our partners, who participated with great enthusiasm in a wide range of kick-off events at the beginning of the year. With LR ZEITGARD Signature, we have perfectly complemented our portfolio in the area of colour cosmetics. We are confident that this solid foundation will enable us to continue our growth trajectory in the year of LR’s 40th anniversary,” says Dr. Andreas Laabs, CEO of LR Health & Beauty SE.
In the fourth quarter of 2024, LR Health & Beauty SE generated EBITDA reported of EUR 8.3 million (Q4 2023: EUR 9.0 million). On a preliminary basis, EBITDA reported for the full year 2024 reached EUR 27.3 million, compared to EUR 31.4 million in 2023 and was therefore in line with the forecast for EBITDA reported adjusted in November to EUR 26 to 29 million. In particular, one-off extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024 had a negative impact on the earnings development in the financial year. Normalized EBITDA decreased to EUR 9.5 million in the fourth quarter of 2024, compared to EUR 10.2 million in the fourth quarter of the previous year. In the full year 2024, normalized EBITDA reached EUR 32.6 million on a preliminary basis (2023: EUR 35.4 million).
Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations at LR Health & Beauty SE, comments: “In 2025, we will continue to focus on implementing further strategic measures. For example, we are stepping up the development of new product innovations in order to expand our range of high-quality nutritional supplements and cosmetic products. We will also focus on increasing the efficiency and profitability of the LR Group through operational improvements in production and logistics as well as the further digitalization of our sales activities.”
The report for the fourth quarter of 2024 is available online from today on the company website at https://ir.lrworld.com/. The final, audited figures for the 2024 financial year will be published on the company website at the end of April 2025, together with the annual report.
* As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the fourth quarter and the full year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH.
LR Group
Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.
LR currently has around 1,200 employees and hundreds of thousands of registered community members.
Your Contacts:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de